Implementation of a new strategy and launch of a capital increase
21/04/2023 – AB Science announces today the implementation of a new strategy and the launch, in support of this new strategy, of a capital increase
AB Science
Masitinib and AB8939 – Two compounds with breakthrough mechanism of action
